Original research article| Volume 89, ISSUE 5, P368-373, May 2014

Provider acceptability of Sayana® Press: results from community health workers and clinic-based providers in Uganda and Senegal



      Sayana® Press (SP), a subcutaneous formulation of depot medroxyprogesterone acetate (DMPA) in Uniject™, has potential to be a valuable innovation in family planning (FP) because it may overcome logistic and safety challenges in delivering intramuscular DMPA (DMPA IM). However, SP's acceptability is unknown. We measured acceptability of SP among clinic-based providers (Senegal only) and community health workers.

      Study design

      This open-label observational study was conducted in clinics in three districts in Senegal and community-based services in two districts in Uganda. Providers administered SP to clients seeking reinjection of DMPA IM. We conducted in-depth interviews with 86 providers (52 in Senegal, 34 in Uganda) to assess their experiences providing SP to clients.


      Almost all providers (84/86; 98%) preferred SP over DMPA IM. The main reason Uganda providers preferred SP was the prefilled/all-in-one design made preparation and administration easier and faster. Some providers thought the SP all-in-one feature may decrease stock outs (DMPA IM requires syringe and vial). Providers also felt clients preferred the shorter SP needle because it is less intimidating and less painful. Similarly, the main reasons Senegal providers preferred SP were its characteristics (prefilled/all-in-one) and client preference (especially less pain). They also saw a potential to increase access to FP, especially through community-based distribution. Providers from both countries reported SP introduction would be enhanced through client counseling and community engagement. Providers also said SP must be accessible, affordable and in stock.


      Almost all providers preferred SP over DMPA IM. Provider recommendations should be considered during SP introduction planning.


      We found that SP was acceptable to both clinic-based FP providers and community health workers. Providers' positive attitudes towards SP may facilitate introduction and uptake of this method.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Contraception
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • DHS
        Uganda demographic and health survey 2011. Kampala, Uganda and Calverton, Maryland2012
      1. DHS. 2010–11 Senegal demographic and health and multiple indicators survey: key findings. Calverton, Maryland: 2012.

      2. WHO, USAID, FHI. Community-based health workers can safely and effectively administer injectable contraceptives: conclusions from a technical consultation. Research Triangle Park, North Carolina: World Health Organization (WHO), United States Agency for International Development (USAID), Family Health International (FHI), 2009.

        • Krueger K.
        • Akol A.
        • Wamala P.
        • Brunie A.
        Scaling up community provision of injectables through the public sector in Uganda.
        Studies in Family Planning. 2011; 42: 117-124
        • Stanback J.
        • Mbonye A.K.
        • Bekiita M.
        Contraceptive injections by community health workers in Uganda: a nonrandomized community trial.
        Bulletin of the World Health Organization. 2007; 85: 768-773
      3. FHI, CEFOREP, MOH, ChildFund-Senegal. Documentation du processus de l'offre initiale de pilules (OIP) par les matrones des cases de santé: Rapport Final. Research Triangle Park, NC: Family Health International (FHI), 2010.

      4. FHI 360. Senegal research brief: community health workers successfully provide intramuscular injectable contraception. Research Triangle Park, NC: FHI 360/PROGRESS project, 2013.

        • Guest G.
        • Bunce A.
        • Johnson L.
        How many interviews are enough? An experiment with data saturation and variability.
        Field Methods. 2006; 18: 59-82
        • Burke H.M.
        • Perry B.
        • Packer C.
        • Mueller M.P.
        • Bufumbo L.
        • Mbengue D.
        Training family planning providers to administer Depo-subQ in Uniject (Sayana® Press) — an evaluation. FHI 360, Research Triangle Park, NC2013
      5. QSR. NVivo qualitative data analysis software. ed: QSR International Pty Ltd.; 2011.

        • Mack N.
        • Woodsong C.
        • MacQueen K.
        • Guest G.
        • Namey E.
        Qualitative research methods: a data collector's field guide.
        Family Health International, Research Triangle Park, NC2005
        • Ulin P.
        • Robinson E.
        • Tolley E.
        • McNeill E.
        Qualitative methods: a field guide for applied research in sexual and reproductive health.
        Family Health International, North Carolina, USA2002
        • Bahamondes L.
        • Marchi N.M.
        • de Lourdes Cristofoletti M.
        • Nakagava H.M.
        • Pellini E.
        • Araujo F.
        • et al.
        Uniject® as a delivery system for the once-a-month injectable contraceptive Cyclofem® in Brazil.
        Contraception. 1996; 53: 115-119
        • Sutanto A.
        • Suarnawa I.M.
        • Nelson C.M.
        • Stewart T.
        • Soewarso T.I.
        Home delivery of heat-stable vaccines in Indonesia: outreach immunization with a prefilled, single-use injection device.
        Bulletin of the World Health Organization. 1999; 77: 119-126
        • Tsu V.D.
        • Sutanto A.
        • Vaidya K.
        • Coffey P.
        • Widjaya A.
        Oxytocin in prefilled Uniject™ injection devices for managing third-stage labor in Indonesia.
        International Journal of Gynecology and Obstetrics. 2003; 83: 103-111
        • Darroch J.E.
        • Sedgh G.
        • Ball H.
        Contraceptive technologies: responding to women's needs.
        Guttmacher Institute, New York2011